Published in PLoS One on June 07, 2011
Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration. Proc Natl Acad Sci U S A (2014) 0.90
Synchronous primary cancers of the thyroid and breast: A case report and review of the literature. Oncol Lett (2014) 0.86
Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons. J Neurosci Res (2015) 0.86
Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget (2015) 0.80
The sonic hedgehog-induced type 3 deiodinase facilitates tumorigenesis of basal cell carcinoma by reducing Gli2 inactivation. Endocrinology (2014) 0.77
TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATION. Mol Med (2016) 0.75
Thyroid states regulate subcellular glucose phosphorylation activity in male mice. Endocr Connect (2017) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Histone deacetylases and cancer. Oncogene (2007) 4.30
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol (2001) 2.93
"Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med (2008) 2.85
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res (2009) 1.75
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol (2005) 1.66
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res (2009) 1.63
Role of progesterone in endometrial cancer. Semin Reprod Med (2010) 1.53
Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol (1997) 1.52
Breast cancer in association with thyroid disorders. Breast Cancer Res (2003) 1.34
Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. Mol Cell (2005) 1.30
Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol (2002) 1.30
A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation. Cell (1993) 1.30
Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J (1999) 1.25
Thyroid hormone action: a binding contract. J Clin Invest (2003) 1.24
Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology (1979) 1.22
Endocrine therapy--current benefits and limitations. Breast Cancer Res Treat (2005) 1.21
Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem (2002) 1.21
Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta (1992) 1.21
Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol (2006) 1.19
Endocrine treatment in prostate cancer. Semin Surg Oncol (2000) 1.18
Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett (2011) 1.17
Breast cancer in developing countries. Lancet (2009) 1.16
Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J Clin Invest (2003) 1.16
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem (2003) 1.15
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene (2002) 1.15
Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem (1999) 1.13
Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep (2003) 1.12
The thyroid and breast cancer: a significant association? Ann Med (1997) 1.10
HDAC inhibition decreases the expression of EGFR in colorectal cancer cells. PLoS One (2011) 1.05
Nonbiased identification of DNA sequences that bind thyroid hormone receptor alpha 1 with high affinity. J Biol Chem (1993) 1.05
Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest (2005) 1.05
Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol Endocrinol (2005) 1.04
Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol (2005) 1.02
A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl)hydrazone. J Med Chem (2009) 1.00
Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem Biophys Res Commun (1998) 0.99
A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol (1998) 0.98
Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHalpha promoter. PLoS One (2010) 0.97
The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. J Biol Chem (2002) 0.97
Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J (1995) 0.95
Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol (2009) 0.95
Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element. J Biol Chem (2002) 0.92
Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase. Oncogene (2004) 0.91
Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res (2010) 0.90
In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Endocrinology (2009) 0.90
Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res (1978) 0.89
A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter. J Biol Chem (2005) 0.89
Negative regulation of superoxide dismutase-1 promoter by thyroid hormone. Mol Pharmacol (2006) 0.89
Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors. Oncogene (2011) 0.88
Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. J Mol Endocrinol (2006) 0.88
Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab (1999) 0.88
Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites. BMC Mol Biol (2008) 0.87
Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol Carcinog (2002) 0.86
Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. Mol Endocrinol (2004) 0.85
Over-expression of Senescence Marker Protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells. Biol Pharm Bull (2009) 0.84
Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer. Anticancer Res (1996) 0.84
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Endocrinology (1992) 0.84
Alterations in expression of senescence marker protein-30 gene by 3,3',5-triiodo-L-thyronine (T3). Mol Cell Biochem (2007) 0.82
Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors. Arq Bras Endocrinol Metabol (2009) 0.81
Inhibition of radiation-induced apoptosis via overexpression of SMP30 in Smad3-knockout mice liver. J Radiat Res (2008) 0.81
Thyroid hormone receptors in human breast cancer: effect of thyroxine administration. Anticancer Res (1987) 0.79
Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res (1997) 0.78
Altered response to thyroid hormones by prostate and breast cancer cells. Cancer Chemother Pharmacol (2000) 0.78
Development of the spinal tract of the trigeminal nerve and its relation to early fetal behavior in rats under normal and hypothyroid conditions. Exp Brain Res (1986) 0.78
Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Cancer Res (2004) 1.59
Functional inactivation of a transcriptional corepressor by a signaling kinase. Nat Struct Biol (2003) 1.50
Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem (2003) 1.34
MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J Biol Chem (2003) 1.07
Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Mol Cell Biol (2004) 0.98
Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes. J Neurooncol (2009) 0.91
Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis. PLoS One (2013) 0.83
Alterations in expression of senescence marker protein-30 gene by 3,3',5-triiodo-L-thyronine (T3). Mol Cell Biochem (2007) 0.82
EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells. Int J Biochem Cell Biol (2013) 0.78
Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3. FEBS Lett (2002) 0.77